UBS Group’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.96M | Buy |
425,915
+81,864
| +24% | +$761K | ﹤0.01% | 3253 |
|
|
2025
Q1 | $2.32M | Buy |
344,051
+155,854
| +83% | +$1.05M | ﹤0.01% | 3603 |
|
|
2024
Q4 | $2M | Buy |
188,197
+108,957
| +138% | +$1.16M | ﹤0.01% | 3713 |
|
|
2024
Q3 | $1.16M | Buy |
79,240
+1,557
| +2% | +$22.8K | ﹤0.01% | 3482 |
|
|
2024
Q2 | $940K | Buy |
77,683
+53,032
| +215% | +$642K | ﹤0.01% | 3449 |
|
|
2024
Q1 | $608K | Buy |
+24,651
| New | +$608K | ﹤0.01% | 3941 |
|
|
2023
Q4 | – | Sell |
-14
| Closed | -$117 | – | 8303 |
|
|
2023
Q3 | $117 | Sell |
14
-1,044
| -99% | -$8.73K | ﹤0.01% | 7700 |
|
|
2023
Q2 | $8.37K | Buy |
1,058
+1,044
| +7,457% | +$8.26K | ﹤0.01% | 6166 |
|
|
2023
Q1 | $70 | Sell |
14
-460
| -97% | -$2.3K | ﹤0.01% | 8189 |
|
|
2022
Q4 | $1.05K | Sell |
474
-14,797
| -97% | -$32.7K | ﹤0.01% | 8773 |
|
|
2022
Q3 | $68K | Buy |
15,271
+13,943
| +1,050% | +$62.1K | ﹤0.01% | 4995 |
|
|
2022
Q2 | $4K | Buy |
1,328
+1,208
| +1,007% | +$3.64K | ﹤0.01% | 8034 |
|
|
2022
Q1 | $1K | Sell |
120
-2,371
| -95% | -$19.8K | ﹤0.01% | 8820 |
|
|
2021
Q4 | $32K | Buy |
2,491
+2,477
| +17,693% | +$31.8K | ﹤0.01% | 6220 |
|
|
2021
Q3 | $0 | Sell |
14
-1,356
| -99% | – | ﹤0.01% | 8547 |
|
|
2021
Q2 | $24K | Buy |
1,370
+922
| +206% | +$16.2K | ﹤0.01% | 6052 |
|
|
2021
Q1 | $15K | Sell |
448
-586
| -57% | -$19.6K | ﹤0.01% | 6602 |
|
|
2020
Q4 | $10K | Buy |
+1,034
| New | +$10K | ﹤0.01% | 6462 |
|